glp-1 review article Frontiers Glucagon-Like Peptide-1 Receptor Agonists in
Description
The pharmaceutical landscape has shifted significantly towards biologics and biosimilars, with a greater emphasis on delivering positive patient experiences
Eur J Pharmacol (2013) 700(1-3):4250
Nature 379:6972
Lowers cravings for sugars and carbs
Conclusion: There is a notable reporting signal of AP associated with all GLP-1 RAs
